Launched in 2010, the French National Organized Colorectal Cancer Screening Program aims to reduce mortality from colorectal cancer through early detection and timely treatment of precancerous lesions.
The participation rate was of 32.1% during the 2010-2011 period, and 29.6% in 2023-2024, a rate that remains below the European benchmark for acceptable coverage, set at 45%.
The program targets women and men aged 50 to 74 years, every two years, provided they have no symptoms, no personal or family history of polyps, colorectal cancer, or related diseases, and no specific risk factors.
The organized screening process consists of two steps:
Screening kits are now available through multiple channels:
Alternative ways of providing the kits are also being evaluated to encourage greater participation in the screening program.
Since January 2024, the National Health Insurance (Assurance Maladie) has implemented the “Aller Vers” initiative to improve access to screening, particularly for the most vulnerable populations. Key features of the initiative include:
Information on reasons for non-participation is also collected to help adapt public awareness campaigns and refine policy interventions.
Other outreach initiatives are currently being tested and implemented.
#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #LungCancer #BreastCancer
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959